1668-S2 AMH MACE CLOD 167
2SHB 1668 - H AMD 1104
By Representative MacEwen
On page 1, beginning on line 16, after "product." strike all material through "reactions." on line 20
On page 2, beginning on line 22, after "(c)" strike all material through "(d)" on page 3, line 1
Reletter the remaining subsections consecutively and correct any internal references accordingly.
On page 7, line 14, after "process marijuana" strike "of natural origin"
On page 10, beginning on line 25, after "(ddd)" strike all material through "(eee)" on line 30
Reletter the remaining subsections consecutively and correct any internal references accordingly.
On page 12, beginning on line 28, strike all of subsection (h)
On page 13, beginning on line 16, after "plant Cannabis" strike all material through "producer, unless" on line 17 and insert "or"
On page 16, beginning on line 27, after "RCW))." strike all material through "this act." on line 34
On page 17, beginning on line 4, strike all of subsections (4) and (5)
Renumber the remaining subsections consecutively and correct any internal references accordingly.
On page 19, beginning on line 16, after "derived cannabinoids" strike "or synthetically derived cannabinoids"
On page 19, beginning on line 35, strike all of sections 7, 8, 9, 10, and 11
On page 26, after line 5, insert the following:
"NEW SECTION. Sec. 13. A new section is added to chapter 69.50 RCW to read as follows:
(1) The Washington State University center for cannabis policy, research, and outreach shall convene a scientific panel, with members as provided in subsection (2) of this section, to review available scientific research, data, and regulations of other jurisdictions related to cannabinoids and the regulation of cannabinoids including, but not limed to:
(a) Definitions of impairing cannabinoids;
(b) Definitions of synthetic cannabinoids, synthetically derived cannabinoids, and artificial cannabinoids; and
(c) Health and safety considerations related to the conversion process and consumption of cannabinoids.
(2) The scientific panel shall consist of the following members:
(a) One representative from Washington State University, designated by the dean of Washington State University;
(b) One representative from the University of Washington, designated by the dean of the University of Washington;
(c) One representative who holds a cannabis research license issued by the board;
(d) One representative from a certified cannabis testing laboratory; and
(e) One person who is a regulatory expert experienced with regulations of the United States food and drug administration on consumable products.
(3) The scientific panel convened under this section shall compile findings and make recommendations to the legislature regarding regulating cannabinoids in the adult-use cannabis market, with a report submitted to the legislature by December 1, 2022, and annual updates to the legislature thereafter."
Renumber the remaining section consecutively, correct any internal references accordingly, and correct the title.
| EFFECT: (1) Removes proposed definitions, prohibitions, and restrictions on artificial and synthetically derived cannabinoids including related to: (a) the ban on the manufacture and sale artificial cannabinoids and their use as additives in cannabis products; (b) the requirement for rulemaking prior to the manufacture and sale of synthetically derived cannabinoids; (c) packaging and labeling disclosures; (d) activities of cannabis processors; and (e) the restrictions on artificial and synthetically derived cannabinoids related to medical cannabis products and the availability of a related sales and use tax exemption.
(2) Requires the Washington State University Center for Cannabis Policy, Research, and Outreach to convene a five-member scientific panel to review available scientific research, data, and regulations of other jurisdictions related to cannabinoids and the regulation of cannabinoids including, but not limited to: (a) Definitions of impairing cannabinoids; (b) definitions of synthetic cannabinoids, synthetically derived cannabinoids, and artificial cannabinoids; and (c) health and safety considerations related to the conversion process and consumption of cannabinoids. Requires a report to the Legislature by December 1, 2022, with annual updates thereafter.
|
--- END ---